Ember.
Sustained focus, neural resilience, executive function.
An 8-week cognitive arc built on Semax, a heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH). Originally developed in Russia for stroke recovery, Ember supports BDNF expression, memory consolidation, and stress resilience.
What's in the vial.
Met-Glu-His-Phe-Pro-Gly-Pro. Administered intranasally for direct nose-to-brain transport via the olfactory pathway.
Increases BDNF and NGF expression in the hippocampus and cortex. Modulates dopaminergic and serotonergic systems. Inhibits enkephalin-degrading enzymes, prolonging endogenous opioid signaling.
What patients report.
- →Sustained attention through long cognitive sessions
- →Improved working memory and recall
- →Reduced mental fatigue under load
- →Neuroprotection against ischemic and oxidative stress
- →Faster reaction time on standardized batteries
Designed for.
- High-output knowledge workers
- Recovery from concussion or cognitive fatigue
- Adults noticing age-related slowing in processing speed
How the arc unfolds.
- 01 · Wk 1–2
Morning intranasal dose, baseline cognitive battery.
- 02 · Wk 3–6
Twice-daily dosing, midpoint reassessment.
- 03 · Wk 7–8
Taper and final cognitive testing.
Average outcomes.
Aggregated from Protokol partner-clinic submissions. Individual results vary.
Other protocols.
Begin Ember.
Every Protokol arc starts with a partner clinician — bloodwork, supervision, and follow-up included.
Start Your Journey →